Clinical Data and Reports
NEWEST CLINICAL STUDY
2020 Final Report: Hand Sanitizer vs COVID-19
Study Conclusions: “Under the conditions of this evaluation Test Product #1 ESC Brands My-shield/Glan Health Advanced Hand Sanitizer (Lot#05122020-HS-A), Reduced the infectivity of Coronavirus strain 229E by >.3.00 log10 (99.90%) following a 30-second and a 60-second exposure.” (FfNAL REPORT 112004279-402 Page 7 of 10 BIOSCIENCE LABORATORJES, fNC.)
______________
Additional clinical trial results for products distributed by Pathogen Shield Technologies:
MY-SHIELD® HOSPITAL STUDY
My-Shield® Sanitizer/disinfectant participated in an extensive third-party sponsored 39-room, 27 day study at a prominent US-based hospital. The objective was to test the potential effectiveness and persistence of the product(s) and record any reduction of bacteria loadings over extended periods as compared to current cleaning & disinfection protocols currently incorporated by the medical facility.
Objectives of the study: To quantify the effectiveness of the My-Shield® nano silicone sanitizer & disinfectant technologies in reducing microbial loadings in a working hospital environment over current cleaning & disinfection protocols.
Study data summary and conclusions: The study included an extensive microbial study with some 370 platelet lab tests conducted – all acquired from 39 different patient rooms in a major working hospital over the course of a 3-week period, under 5 varied cleaning & sanitation protocols.
Category A (Baseline – Only using conventional disinfectant): current hospital cleaning & disinfection by hospital cleaning staff with continued routine cleaning & disinfection for 26 days.
Conclusion: Study A started with the lowest initial bacterial loading and only managed a marginal reduction of just 4% in overall microbial loading for the term of the study.
Category B: one single application of My-Shield® Sanitizing/Disinfection treatment applied by Electrostatic applicator & wipes. (no routine cleaning for 26 days).
Conclusion: Study B started with a modest initial bacterial loading and achieved a 92% reduction in week one, an 83% reduction in week two and a 70% reduction in week three with one single application of My-Shield® and no follow up cleaning.
Category C: one single application of My-Shield® Sanitizer/Disinfectant with combination steam & electrostatic applicator followed up with 26 days of routine cleaning.
Conclusion: Study C started with the third highest initial bacterial loading & achieved a 96% reduction in week one, an 94% reduction in week two and a 93% reduction in week three, with one single application of My-Shield® and continued daily routine cleaning.
Category D: one single application of My-Shield® Sanitizer/Disinfectant treatment applied with a combination of electrostatic applicator and wipes followed up with 26 days of routine cleaning.
Conclusion: Study D started the second highest initial bacterial loading and achieved a 97% reduction in week one, an 95% reduction in week two and a 91% reduction in week three, with one single application of My-Shield® and no continued routine cleaning.
Category E: continued application of My-Shield® Sanitizer/Disinfectant treatment applied with a combination of electrostatic applicator & wipes forming part of the routine cleaning & disinfection with My-Shield® for 26 days.
Conclusion: Study E started with a highest initial bacterial loading & achieved a 98% to 97% reduction in total bacterial loading with continued daily routine cleaning & disinfection with My-Shield®.
Hospital Grade Disinfectant Clinical Study
FELINE INFECTIOUS PERITONITIS (A MERS-CORONAVIRUS SURROGATE)
Objective: Determine the efficacy of My-Shield® Hand Sanitizer Foam against feline infectious peritonitis virus on hands.
Results: My-Shield® Hand Sanitizer was able to achieve a >99.9% (>3.19 log10) reduction. All replicates in the presence My-Shield® Hand Sanitizer Foam were below the limit of detection for the assay suggesting that greater reductions are achievable. Results are shown in Table 1. My-Shield® Hand Sanitizer Foam is effective at reducing feline infectious peritonitis virus (a MERS-coronavirus) on hands by at least 99.9% following manufacturer’s instruction.